Irving Kent Loh, MD, is a cardiologist with expertise in noninvasive cardiovascular care. He is an attending cardiologist at Los Robles Hospital and Medical Center, and the founder and director of the Ventura Heart Institute. His clinical focus includes preventive cardiology and cardiovascular risk reduction, complex lipid and cardiometabolic management, and comprehensive outpatient cardiovascular evaluation. His research interests center on cardiometabolic clinical trials, AI-enabled clinical decision support and digital health technology, and strategies to improve healthcare quality and research integrity. Dr. Loh has served as Co-Founder and Chief Medical Officer of Infermedica and is a global member of the ITU-WHO-WIPO initiative on AI for Health. He has been principal investigator for more than 160 clinical trials, chaired an Institutional Review Board for many years, and founded and chaired a hospital Bio-Ethics Committee. His honors include the California ACC Outstanding Achievement Award, service as Emeritus Chair of the California ACC Technology and Innovation Committee, and receipt of an international Future Forum Grant; he is also a long-running health columnist and TEDx speaker. He earned his MD at the University of California, San Francisco School of Medicine, completed internship and residency training in internal medicine at UCSF, pursued post-graduate research training at the National Institutes of Health, and completed a cardiology fellowship at Cedars-Sinai Medical Center.
Attending Physician
Medical School
1968 – 1972
Residency
1972 – 1974
Fellowship
1977 – 1979